Tumores Gastrintestinais
Diretriz de Consenso | U.S. Multi-Society Task Force sobre câncer colorretal agora sugere que o rastreamento da doença comece aos 45 anos de idade.
22 Nov, 2021 | 09:30hComunicado de imprensa: US Multi-Society Task Force on colorectal cancer releases updated screening recommendations - American Gastroenterological Association
Conteúdos relacionados:
State of the Art Review: Screening and prevention of colorectal cancer.
USPSTF Statement: Start colorectal cancer screening at 45 years for most patients.
ACG Clinical Guidelines: Start colorectal cancer screening at 45
Resultados de longo prazo de estudo randomizado | Quimioradioterapia com indução ou quimioterapia de consolidação como terapia neoadjuvante total para pacientes com câncer retal
19 Nov, 2021 | 12:48hChemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Patients With Locally Advanced Rectal Cancer: Long-term Results of the CAO/ARO/AIO-12 Randomized Clinical Trial – JAMA Oncology (gratuito por tempo limitado)
Entrevista com o autor: Chemoradiotherapy Plus Induction or Consolidation Chemotherapy for Locally Advanced Rectal Cancer – JAMA Oncology
Comentário no Twitter
Secondary analysis of 311 pts on ARO-12 trial of variant approaches to total neoadjuvant therapy (TNT) w/combo of chemo & concurrent chemoradiation (CRT) for rectal cancer shows best results w/up-front CRT then chemo & resection led to best results https://t.co/7cpv5cb1Fr #CRCSM pic.twitter.com/bxfz9Fi5OB
— JAMA Oncology (@JAMAOnc) November 18, 2021
Cuidados de enfermagem para pacientes oncológicos submetidos a cirurgia usando uma abordagem otimizada de recuperação.
17 Nov, 2021 | 12:49hOncologic Surgical Care Using an Enhanced Recovery Approach – AACN Advanced Critical Care
Comunicado de imprensa: Enhanced Recovery Approach Changes Care for Surgical Oncology Patients – American Association of Critical-Care Nurses
Conteúdo relacionado: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines
Quase metade dos pacientes com câncer em uso de gastrostomia descompressiva para nutrição ou obstrução intestinal apresentava doença estágio IV e faleceu em 1 mês da colocação do tubo.
12 Nov, 2021 | 13:27hComentário: Risks and Benefits Associated With Gastrostomy Tubes for Patients With Cancer – The ASCO Post
Estudo randomizado | Rastreamento com sigmoidoscopia flexível uma única vez está associado com redução, no longo prazo, da incidência e mortalidade por câncer colorretal.
10 Nov, 2021 | 12:41hComentários:
Compreendendo uma doença complexa: abordagem prática do manejo de tumores neuroendócrinos.
9 Nov, 2021 | 12:00h
Comentário no Twitter
#Neuroendocrine tumors are heterogeneous with a complex treatment landscape. This #JCOOP Clinical Review discusses optimal management of #NET and key patient/tumor characteristics that can guide treatment selection https://t.co/zZF36E93w8 pic.twitter.com/2xqwOlwIvw
— Journal of Clinical Oncology (@JCO_ASCO) October 28, 2021
M-A | Comparação entre desfechos de quimiorradioterapia neoadjuvante e quimioterapia neoadjuvante em pacientes com câncer esofágico localmente avançado.
8 Nov, 2021 | 12:24hRevisão | Manejo clínico de lesões pancreáticas pré-malignas.
1 Nov, 2021 | 10:51hClinical Management of Pancreatic Premalignant Lesions – Gastroenterology
Estudo randomizado | Gastrectomia distal laparoscópica vs. aberta para câncer gástrico localmente avançado.
26 Out, 2021 | 11:20hLaparoscopic vs Open Distal Gastrectomy for Locally Advanced Gastric Cancer: Five-Year Outcomes From the CLASS-01 Randomized Clinical Trial – JAMA Surgery (gratuito por tempo limitado)
Comentário no Twitter
It is not clear whether laparoscopic (LDG) and open distal gastrectomy (ODG) produce similar long-term outcomes in advanced #gastriccancer. CLASS-01 trial firstly shows LDG results in similar 5-year OS compared to ODG in advanced gastric cancer https://t.co/uUBcLFeqsY
— JAMA Surgery (@JAMASurgery) October 20, 2021
Estudo randomizado | Entre pacientes com câncer colorretal metastático, os randomizados para tratamento sistêmico isolado tiveram menor mortalidade em 60 dias do que aqueles randomizados para ressecção de tumor primário seguida de tratamento sistêmico.
13 Out, 2021 | 12:35hSixty-Day Mortality of Patients With Metastatic Colorectal Cancer Randomized to Systemic Treatment vs Primary Tumor Resection Followed by Systemic Treatment: The CAIRO4 Phase 3 Randomized Clinical Trial – JAMA Surgery (gratuito por tempo limitado)
Editorial: Primary Tumor Resection and Patients With Asymptomatic Colorectal Cancer and Nonresectable Metastases: Results of Recent Randomized Trials – JAMA Surgery (gratuito por tempo limitado)
Comentário: Systemic Therapy Alone Bests Surgical Tx for Metastatic CRC – BreakingMed
Comentário no Twitter
Early mortality in patients with colorectal cancer and unresectable metastases randomized to primary tumor resection followed by systemic treatment is considerably higher than early mortality in patients randomized to systemic treatment only https://t.co/SyfYjmDU7i @DaveKruijssen
— JAMA Surgery (@JAMASurgery) October 11, 2021